Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico.

Arch Osteoporos

R A C Salud Consultores, S.A. de C.V., Insurgentes Sur 598 P-2 204, Col. Del Valle, Deleg. Benito Juárez, 03100, Mexico City, D.F., Mexico.

Published: July 2013

Unlabelled: Different sources were used to estimate the 2010 health care costs of managing low bone density (osteopenia/osteoporosis) plus caring fragility fractures in Mexico at 411 million USD. Figures are projected to rise 42 % by 2020. Preventive and timely interventions are required to decrease the financial burden of these entities.

Introduction: Osteopenia, osteoporosis, and fragility fractures (FF) are a public health concern. The study purpose was to estimate the health care costs of these conditions in Mexico during 2010 and project them to 2015 and 2020.

Methods: Prevalence of osteopenia and osteoporosis was derived from international data. The Mexican version of FRAX® algorithm was used to assess risk for a major FF (hip, clinical spine, forearm, and proximal humerus) in osteopenic and osteoporotic population aged over 40 years. The estimates were applied to national demographic projections. Only direct medical costs composed by routine non-pharmacological management of osteopenia/osteoporosis besides the costs owing to medical care of major FF were considered into the analysis. Resource use for managing osteopenia/osteoporosis was defined from local sources (clinical practice guidelines, published literature, and expert opinion); unit costs were gathered from official lists. Costs for medical care of FF were based on diagnosis-related groups.

Results: In population aged ≥40 years, prevalence of osteopenia and osteoporosis in 2010 was 32.8 and 8 %, respectively. A total of 75,763 FF occurred that year. Costs of managing osteopenia and osteoporosis were 154.9 million USD, whereas medical costs due to FF reached 256.2 million USD. Therefore, the annual health care costs of these entities in 2010 were 411 million USD. Total costs will be 19.2 % higher in 2015, and by 2020, the figures will have increased by 41.7 %.

Conclusions: Low bone density entails substantial epidemiological and financial burden in Mexico, and their impact will grow considerably during the next years.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11657-013-0125-4DOI Listing

Publication Analysis

Top Keywords

osteopenia osteoporosis
20
health care
16
care costs
16
fragility fractures
12
costs
11
osteoporosis fragility
8
fractures mexico
8
costs managing
8
low bone
8
bone density
8

Similar Publications

Objectives: To evaluate the value of ultrasound (US) and shear wave velocity (SWV) to assess muscle in postmenopausal women with osteosarcopenia (OSP).

Methods: This study included 145 postmenopausal women, comprising 115 osteopenia/osteoporosis participants without sarcopenia (OP alone) and 30 OSP participants. All received the evaluation of bone mineral density (BMD), appendicular skeletal muscle mass index (ASMI), handgrip strength, calf circumference, 6-meter walking speed, and 5-time chair stand test.

View Article and Find Full Text PDF

: This study aimed to capture the early metabolic changes before osteoporosis occurs and identify metabolomic biomarkers at the osteopenia stage for the early prevention of osteoporosis. : Metabolomic data were generated from normal, osteopenia, and osteoporosis groups with 320 participants recruited from the Nicheng community in Shanghai. We conducted individual edge network analysis (iENA) combined with a random forest to detect metabolomic biomarkers for the early warning of osteoporosis.

View Article and Find Full Text PDF

Osteoporosis is a systemic skeletal disorder characterized by reduced bone density and an increased risk of fractures, particularly prevalent in the aging population. Osteoporotic complications, including vertebral compression fractures, hip fractures, and distal forearm fractures, affect over 8.9 million individuals globally, placing a significant economic strain on healthcare systems.

View Article and Find Full Text PDF

Introduction: The growing importance of mobile apps in osteoporosis management highlights the crucial need for evaluating their utility and usability, particularly for Osteoporosis support apps. Addressing this need, the mHealth App Usability Questionnaire (MAUQ) was crafted in four different versions, categorized based on the nature of the app (interactive or standalone) and the intended user (patient or provider). Due to its usage by diverse users with varying languages, this questionnaire requires psychometric assessment in multiple languages.

View Article and Find Full Text PDF

Background: Osteoporosis and sarcopenia frequently occur in patients with end-stage renal disease undergoing hemodialysis (HD), and depression is also a common mental health issue in this population. Despite the prevalence of these conditions, the interrelationships among them remain poorly understood in HD patients.

Methods: In this multicenter cross-sectional study, 858 HD patients from 7 dialysis centers were recruited.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!